Encantados de anunciar que Viromii está participando en el proyecto...
Read MoreNoticias
Noticias
Divulgation: a fundamental support for innovation
Innovation can be defined in many ways; it is a...
Read MoreActivity update during the COVID19 lockdown
Finally, after more than 3 months working remotely, we are...
Read MoreTheranostics – An innovative approach against cancer.
During the past months, at Viromii we have been working...
Read MoreGlucose monitoring – A vibrant area with a promising future
Recently, at Viromii we have been working with a new...
Read MoreBiohub VLC – a first step for consolidating Valencia as a Biotech Hub?
In one of the most privileged environments of the city...
Read MoreThe 4 steps of our market validation analysis
As all of you know, we develop services for supporting...
Read MorePhage therapy, the solution for multiresistant bacteria?
Recently, at Viromii, we have been working on a really interesting...
Read MoreInnovative strategies for extending drugs’ market exclusivity.
In the previous post, we explored the different preventive strategies pharma...
Read MoreSME Phase 1, one last call and a long-lasting impact in almost 4000 Start-ups.
For some time at Viromii we have been developing a...
Read MorePreventive strategies for extending drugs’ market exclusivity in US and EU.
In the previous post we could see the greatly negative impact that...
Read MoreWhen pharma companies lose control and exclusivity over a blockbuster.
Lately, at Viromii, we have been working with some really...
Read MoreGuidelines for creating a TTO, what do you have to bear in mind before taking the step?
In the previous post, we explained the impact of the...
Read MoreProfessor’s privilege, does it really impact technology transfer?
Universities are the cradle of knowledge, new technologies and innovation....
Read MoreWhich are the most important performance parameters in ventures and startups?
We, at Viromii. have asked this question to many actors...
Read More